In vitro biologic efficacy of sunitinib drug-eluting beads on human colorectal and hepatocellular carcinoma-A pilot study.
Sunitinib drug eluting beads (DEB) are a novel anti-angiogenic bead preparation for use in transarterial chemoembolization. However, systematic studies of sunitinib DEB's effect on cancer cells have not been reported. Herein, we assess their direct biologic efficacy against carcinoma cell lines...
Main Authors: | Steven Lahti, Johannes M Ludwig, Minzhi Xing, Lingyi Sun, Dexing Zeng, Hyun S Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5383050?pdf=render |
Similar Items
-
Drug-eluting beads in hepatocellular carcinoma
by: Hiroyuki Abe, et al.
Published: (2017-03-01) -
Advances in the treatment of hepatocellular carcinoma using drug-eluting beads
by: Guangxu Wei, et al.
Published: (2020-09-01) -
Transarterial chemoembolization using drug eluting beads for the treatment of hepatocellular carcinoma: Now and future
by: Hyun Young Woo, et al.
Published: (2015-12-01) -
A retrospective pilot study of transarterial chemoembolisation using camrelizumab-eluting Callisphere beads for unresectable hepatocellular carcinoma
by: Xiaonan Shi, et al.
Published: (2023-11-01) -
Drug-eluting bead transarterial chemoembolization for hepatocellular carcinoma: does size really matter?
by: Sieh-Yang Lee, et al.
Published: (2020-05-01)